Artificial Intelligence Regulation in the United States
Rheumatic Disease Clinics of North America · 2026-08 · 52 (3) · 573-587
DOI: 10.1016/j.rdc.2026.03.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2026-08. Verfasst von Suzanne Tamang. Beteiligte Einrichtung: Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Populati…. Hauptthemen laut MEDLINE: Artificial Intelligence, Rheumatology. Die Arbeit nennt 13 Literaturangaben. Gefördert von: NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Artificial intelligence (AI) is increasingly embedded in clinical tools used in rheumatology, including imaging interpretation, longitudinal disease monitoring, and electronic health record-based decision support. AI has moved from the periphery of biomedical research to an operational component of clinical care, increasingly embedded in electronic health records, imaging platforms, and decision support systems. In rheumatology, where care is longitudinal, AI systems offer substantial promise-but also poses distinct risks. Together, these commitments-advancing humanity, ensuring equity, engaging impacted individuals, improving workforce well-being, monitoring performance, innovating and learning, and promoting sustainability-operationalize trustworthy AI systems across a patient's care trajectory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Population Health Sciences, Stanford University, Stanford, CA 94305, USA; Depa…
Förderung
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Tamang, S. (2026). Artificial Intelligence Regulation in the United States. Rheumatic Disease Clinics of North America, 52(3), 573-587. https://doi.org/10.1016/j.rdc.2026.03.006
Vancouver
Tamang S. Artificial Intelligence Regulation in the United States. Rheumatic Disease Clinics of North America. 2026;52(3):573-587. doi:10.1016/j.rdc.2026.03.006
BibTeX
@article{Tamang2026,
author = {Tamang, Suzanne},
title = {Artificial Intelligence Regulation in the United States},
journal = {Rheumatic Disease Clinics of North America},
year = {2026},
volume = {52},
number = {3},
pages = {573--587},
doi = {10.1016/j.rdc.2026.03.006}
}
EUVIMED